Ischemia testing and revascularization in patients with monomorphic ventricular tachycardia: A relic of the past?

Curr Probl Cardiol. 2024 Mar;49(3):102358. doi: 10.1016/j.cpcardiol.2023.102358. Epub 2023 Dec 31.

Abstract

Testing for myocardial ischemia in patients presenting with sustained monomorphic Ventricular Tachycardia(VT) even without evidence of acute myocardial infarction is a tempting strategy that is frequently utilized in clinical practice. Monomorphic VT is mainly caused by re-entry around chronic myocardial scar and active ischemia has no role in its pathogenesis, thus making testing for ischemia futile, at least in theory. This systematic literature review sought to address the usefulness of ischemia testing (mainly coronary angiography) in patients presenting with monomorphic VT through 8 selected studies after evaluating a total of 130 published manuscripts. Particularly, we sought to unveil whether coronary angiography and possibly concomitant revascularization leads to lesser tachycardia recurrence. Our conclusion can be summarized as follows: this approach whether combined with revascularization or not, does not seem to reduce VT recurrence nor does it affect mortality in such patients. Even though most of the published literature points at this direction, validation from randomized controlled trials is imperative.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Coronary Artery Disease*
  • Humans
  • Myocardial Infarction*
  • Myocardial Ischemia* / complications
  • Myocardial Ischemia* / diagnosis
  • Myocardial Ischemia* / pathology
  • Myocardium
  • Tachycardia, Ventricular* / diagnosis
  • Tachycardia, Ventricular* / etiology
  • Tachycardia, Ventricular* / surgery